Medivir’s Chief Financial Officer Erik Björk leaves the company
Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announces that the company’s CFO, Erik Björk, has resigned today, February 7, 2019. Erik Björk, who took on the position as CFO in January 2018, leaves the company at his own request. He will remain in the company for a transitional period. Medivir has initiated a recruitment process for a new CFO. For further information, please contact:Uli Hacksell, CEO, Medivir AB, mobile: +46 (0)73 125 0615. About MedivirMedivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The company is